Ganoderic acid A
CAS No. 81907-62-2
Ganoderic acid A ( —— )
产品货号. M19142 CAS No. 81907-62-2
灵芝酸 A 通过其对核转录因子-kappaB 和激活蛋白-1 的抑制作用介导具有抗肿瘤活性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥938 | 有现货 |
|
| 10MG | ¥1577 | 有现货 |
|
| 25MG | ¥2474 | 有现货 |
|
| 50MG | ¥3618 | 有现货 |
|
| 100MG | ¥4995 | 有现货 |
|
| 500MG | ¥10080 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥1074 | 有现货 |
|
生物学信息
-
产品名称Ganoderic acid A
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述灵芝酸 A 通过其对核转录因子-kappaB 和激活蛋白-1 的抑制作用介导具有抗肿瘤活性。
-
产品描述Ganoderic acids are a class of closely related triterpenoids (derivatives from lanosterol) found in Ganoderma mushrooms. For thousands of years, the fruiting bodies of Ganoderma fungi have been used in traditional medicines in East Asia. Consequently, there have been efforts to identify the chemical constituents that may be responsible for the putative pharmacological effects. There are dozens of ganoderic acids that have been isolated and characterized, of which ganoderic acid A and ganoderic acid B are the most well characterized. Some ganoderic acids have been found to possess biological activities including hepatoprotection, anti-tumor effects, and 5-alpha reductase inhibition.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Apoptosis
-
靶点IL Receptor
-
受体NF-κB
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number81907-62-2
-
分子量516.67
-
分子式C30H44O7
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 29 mg/mL; 56.13 mM
-
SMILESCC(CC(=O)CC(C)C(=O)O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O
-
化学全称(25R)-7β,15α-Dihydroxy-3,11,23-trioxo-5α-lanost-8-en-26-oic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Tildrakizumab
Tildrakizumab (SCH 900222) 是一种人源化抗-IL-23 (p19 亚基) 单克隆抗体。IL-23 是维持 Th17 细胞表型的关键细胞因子。Tildrakizumab 对单链 IL-23 具有高亲和力 (Kd: 136 pM)。Tildrakizumab 对中度至重度斑块状银屑病有效。
-
Bengenin
岩白菜素是一种多酚,是一种具有抗氧化作用的有效抗麻醉剂。
-
Benralizumab
Benralizumab (MEDI-563) (MEDI-563 (anti-IL5RA ); BIW-8405 (anti-IL5RA )) 是一种白介素 5 受体 α(IL-5Rα) 定向的溶细胞单克隆抗体,通过增强抗体依赖性细胞介导的细胞毒性诱导嗜酸性粒细胞直接,快速和几乎完全耗尽。Benralizumab 可用于严重的嗜酸性哮喘研究。
021-51111890
购物车()
sales@molnova.cn

